Market Tracker

08/29 6:01pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

10.14
Data as of Aug 29
 +0.52 / +5.41%
Today’s Change
6.12
Today|||52-Week Range
31.73
-34.28%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close9.62
Today’s open9.78
Day’s range9.68 - 10.20
Volume81,116
Average volume (3 months)79,617
Market cap$101.0M
Dividend yield--
Data as of 4:00pm ET, 08/29/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book9.90

Competitors

 Today’s
change
Today’s
% change
ACSTAcasti Pharma Inc-0.02-1.93%
TLOGTetraLogic Pharmaceu...+0.03+0.68%
CNATConatus Pharmaceutic...+0.16+2.38%
PRANPrana Biotechnology ...+0.07+3.23%
Data as of 3:59pm ET, 08/29/2014

Financials

Next reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts